InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-10.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Beetham Thomas W., Autre. Insider active across 2 companies, notably Magenta Therapeutics, Inc.. In total, 7 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €140k. History available since 14 September 2021. The latest transaction was filed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Beetham Thomas W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,048 shares@ US$30.1942.9% of flowCommon StockSEC:0001193125-26-099014:0
9,409 sharesCommon StockSEC:0001193125-26-092040:0
5,000 shares@ US$23.41100.0% of flowCommon StockSEC:0000950170-24-110485:0
Canonical exit: 26 Dec 2024 (T+90)
3,000 shares@ US$0.943.6% of flowCommon StockSEC:0000899243-22-037435:0
3,000 shares@ US$0.996.8% of flowCommon StockSEC:0000899243-22-021182:0
6,103 shares@ US$6.7386.4% of flowCommon StockSEC:0000899243-21-036598:0
20,000 shares0Common StockSEC:0000899243-21-036332:0
7 of 7 declarations
About Beetham Thomas W.
Beetham Thomas W. is a declarant linked to Magenta Therapeutics, Inc. and Viridian Therapeutics, Inc.\DE, where the role is listed as Autre and Chief Operating Officer. Across 7 filings in total, the 7 sampled filings cover the period from 2021-09-16 to 2026-03-09, with EUR 104722 of buys and EUR 34904 of sells, and the most frequent transaction nature is Attribution.
